Scientific Advisory Board
We are pleased to announce the constitution of our Scientific Advisory Board composed of world-class academic experts and key opinion leaders in the field of theranostics applied to precision oncology.

Prof. Dr. med. Richard P. Baum
DKD Helios Klinik, Wiesbaden, Germany

Prof. Dr. Hans-Jürgen Biersack
Clinic and Polyclinic of the University of Bonn, Germany

PD Dr. Med Patricia Grabowski
Charité Berlin, Germany

Prof. Dr. Michael Hofman
Peter MacCallum Cancer Centre, Melbourne, Australia

Dr. Sze Ting Lee
Olivia Newton-John Cancer Research Institute, Melbourne, Australia

Professor Dr. Chen Liu
Peking University Cancer Hospital, Peking, China

PD Dr. Cristina Müller
ETH Zurich, Switzerland

Prof. Dr. Marianne Pavel
University of Erlangen, Germany

Prof. Dr. Martin Pomper
Johns Hopkins University School of Medicine, Baltimore, USA

Prof. Dr. Vikas Prasad
Mallinckrodt Institute of Radiology, Washington University in Saint Louis, USA

Prof. Dr. Frank Rösch
Johannes Gutenberg-University Mainz, Germany

Prof. Dr. A. Oliver Sartor
Medical Director, Tulane Cancer Center; C. E. and Bernadine Laborde Professor of Cancer Research, USA

Prof. Dr. Mike Sathekge
University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa

Prof. Dr. Wolff H. Schmiegel
Bergmannsheil University Hospital at the Ruhr University, Bochum, Germany

Prof. Dr. Andrew Scott
Olivia Newton-John Cancer Research Institute, Melbourne, Australia

Dr. Ralph Wirtz
Stratifyer Molecular Pathology GmbH, Cologne, Germany